Davis ID - Search Results

1

Urothelial cancers: using biology to improve outcomes.

Pezaro C, Liew MS, Davis ID. Pezaro C, et al. Among authors: davis id. Expert Rev Anticancer Ther. 2012 Jan;12(1):87-98. doi: 10.1586/era.11.195. Expert Rev Anticancer Ther. 2012. PMID: 22149435 Review.

2

Targeted therapies in the treatment of renal cell carcinoma.

Pezaro C, Davis ID. Pezaro C, et al. Among authors: davis id. Curr Med Chem. 2008;15(12):1166-74. doi: 10.2174/092986708784310440. Curr Med Chem. 2008. PMID: 18473811 Review.

3

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer.

Pezaro C, Rosenthal MA, Gurney H, Davis ID, Underhill C, Boyer MJ, Kotasek D, Solomon B, Toner GC. Pezaro C, et al. Among authors: davis id. Am J Clin Oncol. 2009 Aug;32(4):338-41. doi: 10.1097/COC.0b013e31818b946b. Am J Clin Oncol. 2009. PMID: 19363437 Clinical Trial.

4

Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer.

Liew MS, Au-Yeung G, Davis ID. Liew MS, et al. Among authors: davis id. Asia Pac J Clin Oncol. 2012 Mar;8(1):101-2. doi: 10.1111/j.1743-7563.2011.01465.x. Epub 2012 Feb 20. Asia Pac J Clin Oncol. 2012. PMID: 22369451 No abstract available.

5

USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.

Liew MS, Azad A, Tafreshi A, Eapen R, Bolton D, Davis ID, Sengupta S. Liew MS, et al. Among authors: davis id. BJU Int. 2013 Nov;112 Suppl 2:74-82. doi: 10.1111/bju.12384. BJU Int. 2013. PMID: 24127680

6

Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group.

Tafreshi A, Thientosapol E, Liew MS, Guo Y, Quaggiotto M, Boyer M, Davis ID. Tafreshi A, et al. Among authors: davis id. Asia Pac J Clin Oncol. 2014 Mar;10(1):60-5. doi: 10.1111/ajco.12122. Epub 2013 Oct 24. Asia Pac J Clin Oncol. 2014. PMID: 24152417 Clinical Trial.

7

Prostate cancer: measuring PSA.

Pezaro C, Woo HH, Davis ID. Pezaro C, et al. Among authors: davis id. Intern Med J. 2014 May;44(5):433-40. doi: 10.1111/imj.12407. Intern Med J. 2014. PMID: 24816306 Review.

8

Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes.

Eapen R, Liew MS, Tafreshi A, Papa N, Lawrentschuk N, Azad A, Davis ID, Bolton D, Sengupta S. Eapen R, et al. Among authors: davis id. ANZ J Surg. 2015 Jul-Aug;85(7-8):535-9. doi: 10.1111/ans.12772. Epub 2014 Jul 14. ANZ J Surg. 2015. PMID: 25040795

9

'First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer.

Lomax AJ, Parente P, Gilfillan C, Livingston PM, Davis ID, Pezaro C. Lomax AJ, et al. Among authors: davis id. Intern Med J. 2016 Feb;46(2):141-8. doi: 10.1111/imj.12731. Intern Med J. 2016. PMID: 25732203 Review.

10

Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.

Tiu C, Pezaro C, Davis ID, Grossmann M, Parente P. Tiu C, et al. Among authors: davis id. Asia Pac J Clin Oncol. 2015 Jun;11(2):190-4. doi: 10.1111/ajco.12348. Epub 2015 Apr 9. Asia Pac J Clin Oncol. 2015. PMID: 25855890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters